An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma

NCT00599027 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis
Asthma

Interventions

DRUG: Mometasone furoate nasal spray (MFNS)
DRUG: Placebo nasal spray

Sponsor

Organon and Co